2021 CDC STI (STD) Guidelines

The 2021 Sexually Transmitted Infections (STI) Treatment Guidelines are here! This universal app works well for both iPhones and iPads (iOS 12+ required). This is the most readable reference with user-defined font sizes for the iPhone, and is completely readable in both landscape and portrait modes. Also, the COMPLETE guidelines are embedded so you can educate yourself even without Internet access.

Our version of the guidelines has been one of the first apps for any provider who diagnoses and treats STIs to buy, including residents, midwives, and nurses. This app was designed and developed by a board-certified Obstetrician/Gynecologist who understands how to quickly answer your questions about STI treatments.

STI 2021 contains the CDC STI Treatment Guidelines with the original, but difficult to navigate, table of contents. So, we have also provided a more clinician-friendly organization of these same guidelines so that clinicians can find conditions and their treatments much faster. STD 2021 also contains a glossary, literature references, as well as the guidelines, pocket guides in PDF formats.

DISCLAIMER: This adaptation is meant ONLY for adults who are licensed healthcare professionals. This material is not meant to serve as a substitute for your own clinical judgment and knowledge as a healthcare professional. You should exercise your professional judgment in evaluating any information contained within this application. We encourage you to confirm the information made available here with other sources before undertaking any treatment based on information in this app. The use of this information is at your own risk and this content is provided on an "AS IS" basis. Healthcare professionals should not exclusively rely on this adaptation, but are referred to the current online version or the electronic PDF version available at https://www.cdc.gov/std/treatment-guidelines/default.htm for the complete CDC STI Treatment Guidelines.

更新履歴
Fixed a typo for parenteral treatment of pelvic inflammatory disease with Ceftriaxone. The correct dosage is 1 g every 24 hours (and NOT every 12 hours).

As a reminder, licensed healthcare providers should exercise their professional judgment in evaluating any information in the app, and we encourage them to confirm the information made available here with other sources before undertaking any treatment based on it. A PDF version of the official guidelines is included in this application for reference.